{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:09:05Z","timestamp":1788408545418,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.cld.2006.05.006","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:10:36Z","timestamp":1168441836000},"page":"371-385","source":"Crossref","is-referenced-by-count":15,"title":["Hepatorenal Syndrome"],"prefix":"10.1016","volume":"10","author":[{"given":"Andr\u00e9s","family":"C\u00e1rdenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2006.05.006_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites","volume":"350","author":"Gin\u00e8s","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2006.05.006_bib3","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.05.006_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00042737-199909000-00004","article-title":"Renal failure in acute liver failure","volume":"11","author":"Moore","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.05.006_bib6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"5","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.cld.2006.05.006_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2036.2004.02111.x","article-title":"Hepatorenal syndrome\u2014definitions and diagnosis","volume":"20","author":"Moreau","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2006.05.006_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib10","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib11","series-title":"Ascites and renal dysfunction in liver disease","first-page":"43","article-title":"The renin-angiotensin-aldosterone system in cirrhosis","author":"Bernardi","year":"2005"},{"key":"10.1016\/j.cld.2006.05.006_bib12","series-title":"Ascites and renal dysfunction in liver disease","first-page":"54","article-title":"The sympathetic nervous system in cirrhosis","author":"Dudley","year":"2005"},{"key":"10.1016\/j.cld.2006.05.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.2003.01647.x","article-title":"Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion","volume":"58","author":"Ishikawa","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2006.05.006_bib14","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0168-8278(03)00007-2","article-title":"Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management","volume":"38","author":"Arroyo","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib15","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis. Value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.05.006_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz del Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib17","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib18","series-title":"Ascites and renal dysfunction in liver disease","first-page":"305","article-title":"Management of hyponatremia in cirrhosis","author":"C\u00e1rdenas","year":"2005"},{"key":"10.1016\/j.cld.2006.05.006_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis","volume":"154","author":"Caregaro","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cld.2006.05.006_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/ajkd.2003.50035","article-title":"Assessing renal function in cirrhotic patients: problems and pitfalls","volume":"41","author":"Sherman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cld.2006.05.006_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1572-0241.2005.40952.x","article-title":"Hepatorenal syndrome: a dreaded complication of end-stage liver disease","volume":"100","author":"C\u00e1rdenas","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2006.05.006_bib22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.05.006_bib23","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/jhep.2001.27830","article-title":"Renal failure after upper gastrointestinal bleeding in cirrhosis. Incidence, clinical course, predictive factors and short-term prognosis","volume":"34","author":"C\u00e1rdenas","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.20373","article-title":"Effects of contrast media on renal function in patients with cirrhosis: a prospective study","volume":"40","author":"Guevara","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib26","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1572-0241.2002.05920.x","article-title":"Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center","volume":"97","author":"Watt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2006.05.006_bib27","first-page":"543A","article-title":"Retrospective analysis of 140 patients labeled as hepatorenal syndrome in a referral center","volume":"42","author":"Servin-Abad","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.510300430","article-title":"Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine","volume":"30","author":"Gulberg","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome","volume":"29","author":"Hadengue","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib32","first-page":"15","article-title":"Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study","volume":"64","author":"Mulkay","year":"2001","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.cld.2006.05.006_bib33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2006.05.006_bib34","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","article-title":"Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"14","author":"Alessandria","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome. Results of a prospective, non-randomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00042737-200202000-00009","article-title":"Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study","volume":"14","author":"Halimi","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib37","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","article-title":"Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis","volume":"17","author":"Colle","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib39","first-page":"78","article-title":"Terlipressin and gelafundin: safe therapy of hepatorenal syndrome","volume":"9","author":"Saner","year":"2004","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cld.2006.05.006_bib40","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00042737-200308000-00015","article-title":"Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome","volume":"15","author":"Saner","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib41","first-page":"206A","article-title":"Terlipressin for hepatorenal syndrome: a Cochrane systematic review","volume":"42","author":"Gluud","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib42","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenaline and albumin in patients with type 1 hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib45","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfh930","article-title":"Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study","volume":"20","author":"Kiser","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cld.2006.05.006_bib46","series-title":"Ascites and renal dysfunction in liver disease","first-page":"341","article-title":"Hepatorenal syndrome in cirrhosis: clinical features, diagnosis, and management","author":"Arroyo","year":"2005"},{"key":"10.1016\/j.cld.2006.05.006_bib47","series-title":"Update in treatment of liver disease","first-page":"19","article-title":"Circulatory dysfunction in cirrhosis","author":"Arroyo","year":"2005"},{"key":"10.1016\/j.cld.2006.05.006_bib48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2006.05.006_bib51","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cld.2006.05.006_bib52","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cld.2006.05.006_bib53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1081\/JDI-200035988","article-title":"The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis","volume":"26","author":"Kapling","year":"2004","journal-title":"Ren Fail"},{"key":"10.1016\/j.cld.2006.05.006_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08860229509026250","article-title":"Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with hepatorenal syndrome): the role of hemodialysis","volume":"17","author":"Keller","year":"1995","journal-title":"Ren Fail"},{"key":"10.1016\/j.cld.2006.05.006_bib55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzer","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2006.05.006_bib56","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000086552","article-title":"The Prometheus device for extracorporeal support of combined liver and renal failure","volume":"23","author":"Rifai","year":"2005","journal-title":"Blood Purif"},{"key":"10.1016\/j.cld.2006.05.006_bib57","series-title":"Ascites and renal dysfunction in liver disease","first-page":"271","article-title":"Liver transplantation for patients with cirrhosis and ascites","author":"Rimola","year":"2005"},{"key":"10.1016\/j.cld.2006.05.006_bib58","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.jhep.2004.12.007","article-title":"Management of complications of cirrhosis in patients awaiting liver transplantation","volume":"42","author":"C\u00e1rdenas","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2006.05.006_bib59","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/lt.20445","article-title":"Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation","volume":"11","author":"Campbell","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2006.05.006_bib60","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fernandez","year":"2005","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326106000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326106000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T02:50:20Z","timestamp":1547088620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326106000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1089326106000079"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2006.05.006","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}